Skip to content
OpenCapital
AI Tools
Earnings
Screener
Charts
Watchlist
Pricing
Connect your AI
Get started
Toggle navigation menu
Vuzix
VUZI
Concentration Risk %
Concentration Risk % at other companies
Identive
INVE
10.3%
+7.7pp
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
RF Industries
RFIL
100%
0.0pp
Weis Markets
WMK
100%
0.0pp
Segments
By geography
See full
North America
70%
+25.0%
Europe
20%
-41.2%
Other Continent
18%
-33.3%
Asia Pacific
8%
+14.3%
By product
See full
Engineering Services
72%
+67.4%
Other financials
Income statement
See full
Revenue
$1.4M
-12.0%
Gross profit
-$377.9K
-42.5%
Operating income
-$7.2M
+17.9%
Net income
-$7.1M
+18.1%
EPS (diluted)
-$0.09
+18.2%
Balance sheet
See full
Cash & equivalents
$20.2M
+32.4%
Total debt
$872.2K
+143%
Total equity
$24.0M
-26.9%
Total assets
$38.4M
+7.3%
Cash flow
See full
Operating cash flow
-$5.6M
-60.9%
CapEx
$996.4K
+62.4%
Free cash flow
-$6.6M
-61.1%
Valuation
See full
Market cap
$241.16M
+9.8%
Enterprise value
$221.86M
+9.6%
P/S
39.6×
-0.1×
Profitability
See full
Gross margin
-19.3%
-8.7pp
Operating margin
-507.9%
-196pp
Net margin
-504.1%
-194pp
FCF margin
-382.3%
+2.4pp
Returns & leverage
See full
Return on equity
-108%
-18.5pp
Debt / equity
0×
0.0×
Current ratio
6.2×
-1.5×